Acadian Asset Management
NXTC icon

Acadian Asset Management’s NextCure NXTC Stock Holding History

Acadian Asset Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$199K Sell
18,982
-7,783
-29% -$95.1K ﹤0.01% 1590
2025
Q4 		$379K Sell
26,765
-9,910
-27% -$103K ﹤0.01% 1385
2025
Q3 		$213K Sell
36,675
-4,028
-10% -$21.1K ﹤0.01% 1391
2025
Q2 		$223K Hold
40,703
– – ﹤0.01% 1288
2025
Q1 		$233K Hold
40,703
– – ﹤0.01% 1230
2024
Q4 		$375K Hold
40,703
– – ﹤0.01% 1136
2024
Q3 		$667K Hold
40,703
– – ﹤0.01% 1017
2024
Q2 		$774K Hold
40,703
– – ﹤0.01% 1076
2024
Q1 		$1.09M Hold
40,703
– – ﹤0.01% 818
2023
Q4 		$556K Hold
40,703
– – ﹤0.01% 1009
2023
Q3 		$628K Hold
40,703
– – ﹤0.01% 951
2023
Q2 		$878K Hold
40,703
– – ﹤0.01% 912
2023
Q1 		$721K Buy
40,703
+4,831
+13% +$93K ﹤0.01% 962
2022
Q4 		$605K Buy
35,872
+10,819
+43% +$249K ﹤0.01% 983
2022
Q3 		$825K Sell
25,053
-482
-2% -$24.6K ﹤0.01% 849
2022
Q2 		$1.44M Sell
25,535
-2,330
-8% -$122K 0.01% 723
2022
Q1 		$1.62M Buy
27,865
+1,250
+5% +$78.2K 0.01% 709
2021
Q4 		$1.92M Buy
26,615
+18,079
+212% +$1.51M 0.01% 669
2021
Q3 		$689K Buy
8,536
+132
+2% +$11.6K ﹤0.01% 956
2021
Q2 		$810K Buy
8,404
+5,464
+186% +$559K ﹤0.01% 991
2021
Q1 		$354K Buy
+2,940
New +$426K ﹤0.01% 1312

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Acadian Asset Management's NXTC Position: Q1 2026 in Review

Acadian Asset Management reduced its NextCure (NXTC) stake by 29% in Q1 2026, selling an estimated $95.1K and leaving 18,982 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

Acadian Asset Management first reported a position in NXTC in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.92M in Q4 2021. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • Acadian Asset Management held 18,982 shares of NextCure worth $199K as of Q1 2026.
  • Acadian Asset Management sold 7,783 NextCure shares in Q1 2026, an estimated $95.1K.
  • NextCure made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1590 holding.
  • Acadian Asset Management first reported a position in NextCure in Q1 2021 and has held it in 21 quarters since.
  • Acadian Asset Management's NextCure position peaked at $1.92M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.